Literature DB >> 7904450

The mortality and pathology of HIV infection in a west African city.

S B Lucas1, A Hounnou, C Peacock, A Beaumel, G Djomand, J M N'Gbichi, K Yeboue, M Hondé, M Diomande, C Giordano.   

Abstract

BACKGROUND: HIV disease is epidemic in Africa, but associated mortality, underlying pathology and CD4+ T-lymphocyte counts have not previously been evaluated in a representative study. Such data help to determine the management of HIV-positive people. Both HIV-1 and HIV-2 infections are prevalent in Côte d'Ivoire, and the pathology of HIV-2 infection in Africa is unclear.
METHODS: Consecutive adult medical admissions to a large city hospital in Côte d'Ivoire were studied in 1991, and a sample of HIV-positive deaths autopsied.
RESULTS: Of 5401 patients evaluated, 50% were HIV-positive; 38% of these died, with a median survival of 1 week. At autopsy (n = 294, including 24% of HIV-positive deaths in hospital), tuberculosis (TB), bacteraemia (predominantly Gram-negative rods) and cerebral toxoplasmosis caused 53% of deaths. TB was seen in 54% of cadavers with AIDS-defining pathology and Pneumocystis pneumonia in 4%. The median CD4+ T-lymphocyte counts in those who died was < 90 x 10(6)/l. Compared with HIV-1-positives, patients with HIV-2-positivity had a greater frequency of severe cytomegalovirus infection, HIV encephalitis and cholangitis.
CONCLUSIONS: In this population, HIV-positive adults present to hospital with advanced disease associated with high mortality. The three major underlying pathologies (TB, toxoplasmosis and bacteraemia) are either preventable or treatable. TB is an underestimated cause of the 'slim' syndrome in Africa. The patterns of pathology in HIV-2-positive patients suggest a more prolonged terminal course compared with HIV-1. There is an urgent need for attention towards the issues of therapy and care for HIV disease in developing countries.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Causes Of Death; Demographic Factors; Developing Countries; Diseases; Examinations And Diagnoses; French Speaking Africa; Hiv Infections; Infections; Ivory Coast; Laboratory Examinations And Diagnoses; Mortality; Population; Population Dynamics; Tuberculosis; Viral Diseases; Western Africa

Mesh:

Year:  1993        PMID: 7904450     DOI: 10.1097/00002030-199312000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  126 in total

Review 1.  Global impact of human immunodeficiency virus and AIDS.

Authors:  H D Gayle; G L Hill
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 2.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

3.  Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

Authors:  J Ren; L E Bird; P P Chamberlain; G B Stewart-Jones; D I Stuart; D K Stammers
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-17       Impact factor: 11.205

4.  Herpesvirus infection of eye and brain in HIV infected patients.

Authors:  R F Miller; M R Howard; P Frith; C J Perrons; I Pecorella; S B Lucas
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

Review 5.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Performance of nucleic acid amplification following extraction of 5 milliliters of whole blood for diagnosis of Mycobacterium tuberculosis bacteremia.

Authors:  John A Crump; Marion J Tuohy; Anne B Morrissey; Habib O Ramadhani; Boniface N Njau; Venance P Maro; L Barth Reller; Gary W Procop
Journal:  J Clin Microbiol       Date:  2011-10-26       Impact factor: 5.948

7.  Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.

Authors:  Salome Charalambous; Alison D Grant; Craig Innes; Christopher J Hoffmann; Rob Dowdeswell; Jan Pienaar; Katherine L Fielding; Gavin J Churchyard
Journal:  AIDS       Date:  2010-11       Impact factor: 4.177

8.  Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru.

Authors:  Dominique Eza; Gustavo Cerrillo; David A J Moore; Cecilia Castro; Eduardo Ticona; Domingo Morales; Jose Cabanillas; Fernando Barrantes; Alejandro Alfaro; Alejandro Benavides; Arturo Rafael; Gilberto Valladares; Fernando Arevalo; Carlton A Evans; Robert H Gilman
Journal:  Pathol Res Pract       Date:  2006-09-19       Impact factor: 3.250

9.  Reducing the burden of tuberculosis presenting during the initial months of antiretroviral therapy in resource-limited settings.

Authors:  Stephen D Lawn; David J Edwards; Robin Wood
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

10.  HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania.

Authors:  M W Borgdorff; L R Barongo; A H Klokke; J N Newell; K P Senkoro; J P Velema; R M Gabone
Journal:  Genitourin Med       Date:  1995-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.